Leland Gershell
2017 - Tonix Pharmaceuticals Holding
In 2017, Leland Gershell earned a total compensation of $21K as Former Chief Financial Officer at Tonix Pharmaceuticals Holding, a 95% decrease compared to previous year.
Compensation breakdown
| Other | $21,000 |
|---|---|
| Total | $21,000 |
Gershell received $21K in other compensation, accounting for 100% of the total pay in 2017.
Rankings
In 2017, Leland Gershell's compensation ranked 14,601st out of 14,666 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,601 out of 14,666 | 0th |
Division Manufacturing | 5,743 out of 5,768 | 0th |
Major group Chemicals And Allied Products | 2,068 out of 2,074 | 0th |
Industry group Drugs | 1,724 out of 1,730 | 0th |
Industry Pharmaceutical Preparations | 1,325 out of 1,329 | 0th |
Source: SEC filing on April 19, 2018.
Gershell's colleagues
We found three more compensation records of executives who worked with Leland Gershell at Tonix Pharmaceuticals Holding in 2017.